1325 Boylston St Ste 500 Boston, MA 02215 decibeltx.com
Note: Revenues for privately held companies are statistical evaluations.
Decibel Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.
Note: Decibel Therapeutics's revenues are gauged from an analysis of company filings.
Decibel Therapeutics's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Decibel Therapeutics Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Decibel Therapeutics is developing and marketing.
Decibel Therapeutics doesn't have any recent trademark applications, indicating Decibel Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
AMPLIFY Genetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune conditions, infectious diseases, or the immune repertoire
12/18/2020
PROTECT. REPAIR. RESTORE. pharmaceutical preparations for the treatment of hearing, speech recognition, and balance disorders
07/27/2018
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Decibel Therapeutics grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Decibel Therapeutics is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Decibel Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Decibel Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Decibel Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Decibel Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.